Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

22 sept. 2016 06h00 HE | Source: Gemphire Therapeutics

Gemphire Therapeutics to Present Corporate Overview at the Ladenburg Thalmann 2016 Healthcare Conference

LIVONIA, Mich., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
19 sept. 2016 06h00 HE | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Publication of Phase 2 Data for Gemcabene in the Journal of Clinical Lipidology

LIVONIA, Mich., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the...
10 août 2016 16h05 HE | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Closing of Initial Public Offering

NORTHVILLE, Mich., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Nasdaq:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...
04 août 2016 17h57 HE | Source: Gemphire Therapeutics

Gemphire Therapeutics Announces Pricing of Initial Public Offering

NORTHVILLE, Mich., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of...